Have we reached a plateau in adjuvant breast cancer therapy?

Lancet. 2009 Oct 24;374(9699):1421. doi: 10.1016/S0140-6736(09)61862-6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Docetaxel
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Research Design
  • Taxoids / therapeutic use*

Substances

  • Antineoplastic Agents
  • Taxoids
  • Docetaxel